Value of Medicines: An Investigation of Incorporation of Patient Input into Payer Decisions in the U.S.
In the United States (U.S.), payers often adopt austerity measures to regulate the access to new costly innovative medicines as a function of their perception of short-term budget impact and not necessarily the true overall value those innovative drugs may bring forth, and this is…